STOCK TITAN

Gilead officer exercises 2,797 RSUs, 1,347 withheld

Gilead’s chief communications and corporate affairs officer exercised 2,797 RSUs, with part of the resulting shares withheld to cover the exercise price or tax obligations.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GILEAD SCIENCES, INC. (GILD) reported that Chief Comm & Corp Aff Officer Johanna Mercier exercised 2,797 restricted stock units into an equal number of shares of common stock on September 10, 2026. Of these, 1,347 shares of common stock were delivered or withheld to pay the exercise price or tax liability, leaving 25,054 restricted stock units reported as remaining. Each restricted stock unit represents the right to receive one share of common stock and follows a 4-year vesting schedule with 25% vesting after one year and 6.25% vesting quarterly thereafter.

Positive

  • None.

Negative

  • None.
Insider Mercier Johanna
Role Chief Comm & Corp Aff Officer
Type Security Shares Price Value
Exercise Restricted Stock Unit F1, F2 2,797 -- --
Exercise Common Stock F1 2,797 -- --
Exercise Price or Tax Liability Common Stock 1,347 $144.81 $195K
Holdings After Transaction: Restricted Stock Unit — 25,054 contracts (Direct); Common Stock — 119,684 shares (Direct)
Footnotes (2)
  1. F1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  2. F2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Restricted stock units exercised 2,797 units RSUs exercised into common stock on September 10, 2026
Shares delivered/withheld for exercise price or tax liability 1,347 shares Common stock used in code F transaction on September 10, 2026
Reported price per share for tax/exercise transaction $144.81 per share Applied to 1,347 shares in code F transaction
Restricted stock units remaining 25,054 units RSUs reported as held following the September 10, 2026 exercise
Initial vesting tranche 25.0% Vests on the first anniversary of the grant date
Ongoing quarterly vesting rate 6.25% per quarter Applies after the first anniversary until RSUs are fully vested
Restricted Stock Unit financial
"Each restricted stock unit represents the contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
vesting schedule financial
"The restricted stock units have a 4-year vesting schedule"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GILD disclose for Johanna Mercier?

Johanna Mercier exercised 2,797 restricted stock units into common stock on September 10, 2026, and had 1,347 shares of the resulting common stock delivered or withheld to pay the exercise price or tax liability.

How many restricted stock units did Johanna Mercier exercise in GILD stock?

Johanna Mercier exercised 2,797 restricted stock units, converting them into an equal number of Gilead common shares on September 10, 2026.

How many GILD shares were used to cover exercise price or taxes?

The filing reports that 1,347 shares of Gilead common stock were delivered or withheld to pay the exercise price or tax liability related to the September 10, 2026 transaction, at a reported price of $144.81 per share.

What RSU holdings remain for Johanna Mercier after this GILD transaction?

After the September 10, 2026 exercise, Johanna Mercier is reported as holding 25,054 restricted stock units, each representing the contingent right to receive one share of Gilead common stock, subject to vesting.

What is the vesting schedule for Johanna Mercier’s GILD restricted stock units?

The restricted stock units have a 4-year vesting schedule: 25% vest on the first anniversary of the grant date, and the remaining units vest 6.25% quarterly thereafter until fully vested.

Were Johanna Mercier’s GILD transactions made under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is explicitly unchecked, so no Rule 10b5-1 trading plan is reported for these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mercier Johanna

(Last)(First)(Middle)
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE

(Street)
FOSTER CITY CALIFORNIA 94404

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Comm & Corp Aff Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/10/2026M2,797A(1)121,031D
Common Stock09/10/2026F1,347D$144.81119,684D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)09/10/2026M2,797 (2) (2)Common Stock2,797(1)25,054D
Explanation of Responses:
1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Remarks:
/s/ Amy Kim by Power of Attorney for Johanna Mercier09/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading